
Department of Medical Affairs & Pharmacovigilance • Clinical Formulary Monograph
D 92/6 Okhla Phase 1, New Delhi, 110020, India • Medical Helpline: +91 11-47532297 • Email: contact@vrmedhealthcare.com

Fusoceff-200
Extended-Spectrum Oral Third-Generation Cephalosporin
Fusoceff-200
Extended-Spectrum Oral Third-Generation Cephalosporin
Cefpodoxime Proxetil IP equivalent to Cefpodoxime 200mg
Product Clinical Overview
Fusoceff-200 contains Cefpodoxime Proxetil equivalent to Cefpodoxime 200mg, an orally administered third-generation cephalosporin antibiotic. Following oral absorption, it is de-esterified to active cefpodoxime, providing bactericidal activity against a broad spectrum of Gram-positive and Gram-negative pathogens.
More Images
Actual Fusoceff-200 packaging, label panels and blister strip.
Key Ingredients & Pharmacological Profiles
Active chemical constituents, standardized strengths, and physiological roles.
Third-generation cephalosporin prodrug that inhibits bacterial cell wall synthesis.
Approved Clinical Indications
Clinical contexts where this formulation is prescribed under medical supervision.
Pharmacological Mechanism of Action
Cefpodoxime exerts bactericidal action by binding to essential penicillin-binding proteins (PBPs), leading to inhibition of peptidoglycan cross-linking in the bacterial cell wall and subsequent osmotic lysis.
Formulation & Delivery Technology
- High stability against hydrolysis by standard bacterial beta-lactamases
- Activity across common respiratory pathogens including S. pneumoniae and H. influenzae
- Favorable tissue distribution in respiratory mucosa and tonsillar tissue
VR Med Healthcare Pvt. Ltd.
Registered Office & Facility:D 92/6 Okhla Phase 1, New Delhi, 110020, India
Quality Certifications:WHO-GMP Compliant & ISO 9001:2015 Certified
Medical Helpline:+91 11-47532297
Corporate Email:contact@vrmedhealthcare.com
Administration & Packaging Details
1 tablet (200mg) twice daily after food for 5 to 14 days, strictly according to microbiological sensitivity and prescription of a Registered Medical Practitioner.
10 x 1 x 10 Tablets (Alu-Alu Strip)
Store protected from moisture and light at a temperature below 25°C.
This formulation monograph is published strictly for the professional scientific reference and educational use of Registered Medical Practitioners, Hospitals, and Clinical Laboratories. The technical and pharmacological details presented herein do not constitute medical advice, diagnostic opinion, or therapeutic claims. These products must be prescribed, dispensed, and administered strictly in accordance with local drug regulations and under the supervision of a licensed physician. VR Med Healthcare Pvt. Ltd. does not promote self-medication, off-label usage, or unsolicited consumer health claims.
More in Antimicrobial
Enhancing Lives With
Quality Healthcare & Integrity.
VR Med Healthcare has been a trusted benchmark in the Indian pharmaceutical sector since 2010. Headquartered in Okhla Phase 1, New Delhi, our dedicated team of over 100 professionals collaborates with leading physicians and distributors across India to make premium medicines accessible and reliable.
“Our goal is to deliver quality of care in a courteous, respectful, and compassionate manner. We hope you will allow us to care for you and strive to be the first and best choice for healthcare professionals and families.”
Kamal Choudhary
Managing Director, VR Med Healthcare
Established
Approved Formulations
Healthcare Specialists
Manufacturing Standard
